Bio DG Enters Agreement with a Leader in the Field of Peripheral Vascular Stenting for Exclusive Rights to Novel Absorbable Alloy Technology

SAN DIEGO, May 11, 2016 /PRNewswire/ -- Bio DG is pleased to announce that they have entered into an agreement with a leader in the field of peripheral vascular stenting for the exclusive licensing of Bio DG's proprietary absorbable alloy technology.

Bio DG's alloys are formulated specifically for absorbable medical devices. The technology is unique because the absorption occurs from the surface inward, without compromising the integrity of the remaining implant. Other absorbable alloys can degrade along grain boundaries, which can destabilize the structure causing fracturing and particulation of the implant.

The alloys are fabricated from well-tolerated elements and can be produced in multiple strength and duration profiles. The alloys have austenitic structures and are MRI safe.

"These alloys were developed with the desired characteristics to improve long-term patient outcomes," says Bio DG CEO Gordon Janko. "We are pleased to partner with a company that sees the potential benefits these alloys can bring to stenting products. This is the first of many medical device partnerships we plan to establish."

From a manufacturing standpoint, the absorbable alloy processes like existing medical grade alloys and can be incorporated into a production line without equipment or process changes.

The deal was facilitated by Advancing Medical Innovations (AMI) LLC. AMI was formed to help small entrepreneurial healthcare companies move their products to larger, developed companies and reduce the amount of venture capital required.

About Bio DG
Bio DG is a privately held corporation in the San Diego, CA area. The company focus is on developing absorbable alloys that are based on the patented alloy structure that causes degradation to take place from the surface without pre-mature loss of structural properties of the implanted device. Bio DG partners with medical device manufacturers to develop innovative absorbable medical devices that improve patient outcomes.

Contact:
Warren Pelissier, AMI, LLC
781-749-9290
[email protected]

SOURCE Bio DG